NASDAQ · BIOS
BioPlus Acquisition Corp.
$10.80-$0.01 (-0.05%)
BioPlus Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.58% below the high.
Loading market information…
NASDAQ · PANA · USD
Stock price, earnings
Quote as of Apr 18, 2023, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Panacea Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 6.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Panacea Acquisition Corp. II’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Panacea Acquisition Corp. II, which was established in 2021 and is headquartered in San Francisco, California, does not currently conduct substantial business operations. Its central aim is to complete a strategic business combination, such as an acquisition, merger, or reorganization, with one or more enterprises within the biotechnology industry.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$10.80-$0.01 (-0.05%)
BioPlus Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.58% below the high.
$11.02+$0.02 (+0.18%)
FTAC Emerald Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 25.29% below the high.
$16.52+$3.12 (+23.28%)
CF Acquisition Corp. VIII’s quoted price sits in the lower half of its reported 52-week range, 49.79% below the high.
$12.42-$0.89 (-6.69%)
Thunder Bridge Capital Partners IV Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.03% below the high.
$10.38-$0.02 (-0.19%)
Sustainable Development Acquisition I Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.57% below the high.
$10.30-$0.87 (-7.79%)
Kernel Group Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 27.46% below the high.
$11.45+$0.95 (+9.05%)
LatAmGrowth SPAC’s quoted price sits in the lower half of its reported 52-week range, 23.67% below the high.
$6.28-$3.72 (-37.2%)
InFinT Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 53.79% below the high.
